Lawmaker calls for tax waiver over rare disease treatments
Published: 2009-04-02 06:56:00
Updated: 2009-04-02 06:56:00
A lawmaker has proposed a revised bill that that the government should implement steps to waiver import duties and value added taxes levied on a medicine that treats a rare disease, such as Elaprase (idursulfase), Naglyzyme (galsulfase) and homocystinuria treatments.
“Taxes imposed on such tre...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
